George L. King
- Ophthalmology top 0.02%
- Retinal Diseases and Treatments 55
- Clinical Biochemistry top 0.02%
- Advanced Glycation End Products research 30
- Endocrinology, Diabetes and Metabolism top 0.05%
- Nephrology top 0.2%
- Chronic Kidney Disease and Diabetes 23
- Physiology top 0.1%
- Nitric Oxide and Endothelin Effects 28
- Adipose Tissue and Metabolism 25
-
- Metabolism, Diabetes, and Cancer 40
- Protein Kinase Regulation and GTPase Signaling 22
-
- Pancreatic function and diabetes 26
- Co-authors
- Lloyd Paul AielloChristian Rask‐MadsenPedro GeraldesEdward P. FeenerC. Ronald KahnNapoleone FerraraDaisuke KoyaAllen C. Clermont
- Partner nations
- United StatesJapanCanada
In The Last Decade
George L. King
272 papers receiving 31.5k citations
Hit Papers
Peers
Comparison fields: 5 of 169
- Ophthalmology 7.0k
- Clinical Biochemistry 3.9k
- Endocrinology, Diabetes and Metabolism 7.3k
- Nephrology 1.9k
- Physiology 6.3k
Countries citing papers authored by George L. King
This map shows the geographic impact of George L. King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George L. King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George L. King more than expected).
Fields of papers citing papers by George L. King
This network shows the impact of papers produced by George L. King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George L. King. The network helps show where George L. King may publish in the future.
Co-authorship network
The 25 scholars most cited alongside George L. King, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 8 | |
| 4 | 2022 | 38 | |
| 5 | 2022 | 7 | |
| 6 | 2021 | 55 | |
| 7 | 2020 | 14 | |
| 8 | 2019 | 46 | |
| 9 | 2012 | 179 | |
| 10 | 2012 | 106 | |
| 11 | 2011 | 115 | |
| 12 | 2011 | 33 | |
| 13 | Ocular Characteristics and Retinopathy Risk Factors in Patients With 50 Years or More of Type 1 Diabetes Mellitus | 2006 | 0 |
| 14 | 2005 | 65 | |
| 15 | d––Tocopherol Reduces Diabetes–Induced Retinal Vascular Leakage and ERG Abnormalities in the Rat | 2004 | 1 |
| 16 | 2001 | 238 | |
| 17 | 2000 | 218 | |
| 18 | Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy | 1998 | 12 |
| 19 | 1995 | 51 | |
| 20 | 1985 | 24 |
About George L. King
George L. King is a scholar working on Ophthalmology, Clinical Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 276 papers that have together received 32.5k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (55 papers), Metabolism, Diabetes, and Cancer (40 papers), Advanced Glycation End Products research (30 papers), Nitric Oxide and Endothelin Effects (28 papers), Pancreatic function and diabetes (26 papers), Adipose Tissue and Metabolism (25 papers), Chronic Kidney Disease and Diabetes (23 papers) and Protein Kinase Regulation and GTPase Signaling (22 papers). The work is most often cited by research in Ophthalmology (7.0k citations), Clinical Biochemistry (3.9k citations) and Endocrinology, Diabetes and Metabolism (7.3k citations). George L. King has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Lloyd Paul Aiello, Christian Rask‐Madsen, Pedro Geraldes, Edward P. Feener, C. Ronald Kahn, Napoleone Ferrara, Daisuke Koya, Allen C. Clermont, Toyoshi Inoguchi and Kerrie J. Way. Their work appears in journals such as Diabetes, Diabetes Care, Journal of Biological Chemistry, Journal of Clinical Investigation and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.